180 related articles for article (PubMed ID: 37077911)
1. Elevated circulating monocytes and monocyte activation in COVID-19 convalescent individuals.
Park J; Dean LS; Jiyarom B; Gangcuangco LM; Shah P; Awamura T; Ching LL; Nerurkar VR; Chow DC; Igno F; Shikuma CM; Devendra G
Front Immunol; 2023; 14():1151780. PubMed ID: 37077911
[TBL] [Abstract][Full Text] [Related]
2. Single-cell RNA sequencing reveals characteristics of myeloid cells in post-acute sequelae of SARS-CoV-2 patients with persistent respiratory symptoms.
Yoon H; Dean LS; Jiyarom B; Khadka VS; Deng Y; Nerurkar VR; Chow DC; Shikuma CM; Devendra G; Koh Y; Park J
Front Immunol; 2023; 14():1268510. PubMed ID: 38259488
[TBL] [Abstract][Full Text] [Related]
3. Reduced monocyte proportions and responsiveness in convalescent COVID-19 patients.
Ravkov EV; Williams ESCP; Elgort M; Barker AP; Planelles V; Spivak AM; Delgado JC; Lin L; Hanley TM
Front Immunol; 2023; 14():1329026. PubMed ID: 38250080
[TBL] [Abstract][Full Text] [Related]
4. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection.
Patterson BK; Francisco EB; Yogendra R; Long E; Pise A; Rodrigues H; Hall E; Herrera M; Parikh P; Guevara-Coto J; Triche TJ; Scott P; Hekmati S; Maglinte D; Chang X; Mora-Rodríguez RA; Mora J
Front Immunol; 2021; 12():746021. PubMed ID: 35082777
[TBL] [Abstract][Full Text] [Related]
5. Intermediate Monocytes with PD-L1 and CD62L Expression as a Possible Player in Active SARS-CoV-2 Infection.
Rutkowska E; Kwiecień I; Kłos K; Rzepecki P; Chciałowski A
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458548
[TBL] [Abstract][Full Text] [Related]
6. Persistence of circulating CD169+monocytes and HLA-DR downregulation underline the immune response impairment in PASC individuals: the potential contribution of different COVID-19 pandemic waves.
Fanelli M; Petrone V; Maracchioni C; Chirico R; Cipriani C; Coppola L; Malagnino V; Teti E; Sorace C; Zordan M; Vitale P; Iannetta M; Balestrieri E; Rasi G; Grelli S; Malergue F; Sarmati L; Minutolo A; Matteucci C
Curr Res Microb Sci; 2024; 6():100215. PubMed ID: 38187999
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic alteration of low-density granulocytes in people with pulmonary post-acute sequalae of SARS-CoV-2 infection.
Dean LS; Devendra G; Jiyarom B; Subia N; Tallquist MD; Nerurkar VR; Chang SP; Chow DC; Shikuma CM; Park J
Front Immunol; 2022; 13():1076724. PubMed ID: 36591237
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2.
Littlefield KM; Watson RO; Schneider JM; Neff CP; Yamada E; Zhang M; Campbell TB; Falta MT; Jolley SE; Fontenot AP; Palmer BE
PLoS Pathog; 2022 May; 18(5):e1010359. PubMed ID: 35617421
[TBL] [Abstract][Full Text] [Related]
9. CCR2 Signaling Restricts SARS-CoV-2 Infection.
Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
[TBL] [Abstract][Full Text] [Related]
10. Monocyte CD169 Expression as a Biomarker in the Early Diagnosis of Coronavirus Disease 2019.
Bedin AS; Makinson A; Picot MC; Mennechet F; Malergue F; Pisoni A; Nyiramigisha E; Montagnier L; Bollore K; Debiesse S; Morquin D; Veyrenche N; Renault C; Foulongne V; Bret C; Bourdin A; Le Moing V; Van de Perre P; Tuaillon E
J Infect Dis; 2021 Feb; 223(4):562-567. PubMed ID: 33206973
[TBL] [Abstract][Full Text] [Related]
11. CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses.
Jalloh S; Olejnik J; Berrigan J; Nisa A; Suder EL; Akiyama H; Lei M; Tyagi S; Bushkin Y; Mühlberger E; Gummuluru S
bioRxiv; 2022 Mar; ():. PubMed ID: 35378756
[TBL] [Abstract][Full Text] [Related]
12. CD169 Defines Activated CD14
Affandi AJ; Olesek K; Grabowska J; Nijen Twilhaar MK; Rodríguez E; Saris A; Zwart ES; Nossent EJ; Kalay H; de Kok M; Kazemier G; Stöckl J; van den Eertwegh AJM; de Gruijl TD; Garcia-Vallejo JJ; Storm G; van Kooyk Y; den Haan JMM
Front Immunol; 2021; 12():697840. PubMed ID: 34394090
[TBL] [Abstract][Full Text] [Related]
13. Immunological profiling in long COVID: overall low grade inflammation and T-lymphocyte senescence and increased monocyte activation correlating with increasing fatigue severity.
Berentschot JC; Drexhage HA; Aynekulu Mersha DG; Wijkhuijs AJM; GeurtsvanKessel CH; Koopmans MPG; Voermans JJC; Hendriks RW; Nagtzaam NMA; de Bie M; Heijenbrok-Kal MH; Bek LM; Ribbers GM; van den Berg-Emons RJG; Aerts JGJV; Dik WA; Hellemons ME
Front Immunol; 2023; 14():1254899. PubMed ID: 37881427
[TBL] [Abstract][Full Text] [Related]
14. Single-cell RNA sequencing reveals characteristics of myeloid cells in pulmonary post-acute sequelae of SARS-CoV-2.
Yoon H; Dean LS; Jiyarom B; Khadka V; Deng Y; Nerurukar VR; Chow DC; Shikuma CM; Devendra G; Koh Y; Park J
bioRxiv; 2023 Aug; ():. PubMed ID: 37577518
[TBL] [Abstract][Full Text] [Related]
15. CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses.
Jalloh S; Olejnik J; Berrigan J; Nisa A; Suder EL; Akiyama H; Lei M; Ramaswamy S; Tyagi S; Bushkin Y; Mühlberger E; Gummuluru S
PLoS Pathog; 2022 Oct; 18(10):e1010479. PubMed ID: 36279285
[TBL] [Abstract][Full Text] [Related]
16. Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection.
Albayrak N; Orte Cano C; Karimi S; Dogahe D; Van Praet A; Godefroid A; Del Marmol V; Grimaldi D; Bondue B; Van Vooren JP; Mascart F; Corbière V
Front Immunol; 2022; 13():769839. PubMed ID: 35422799
[TBL] [Abstract][Full Text] [Related]
17. Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19.
Schultheiß C; Willscher E; Paschold L; Gottschick C; Klee B; Bosurgi L; Dutzmann J; Sedding D; Frese T; Girndt M; Höll JI; Gekle M; Mikolajczyk R; Binder M
J Med Virol; 2023 Jan; 95(1):e28364. PubMed ID: 36458566
[TBL] [Abstract][Full Text] [Related]
18. Monocyte CD169 expression in COVID-19 patients upon intensive care unit admission.
Ortillon M; Coudereau R; Cour M; Rimmelé T; Godignon M; Gossez M; Yonis H; Argaud L; Lukaszewicz AC; Venet F; Monneret G
Cytometry A; 2021 May; 99(5):466-471. PubMed ID: 33547747
[TBL] [Abstract][Full Text] [Related]
19. Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.
Boumaza A; Gay L; Mezouar S; Bestion E; Diallo AB; Michel M; Desnues B; Raoult D; La Scola B; Halfon P; Vitte J; Olive D; Mege JL
J Infect Dis; 2021 Aug; 224(3):395-406. PubMed ID: 33493287
[TBL] [Abstract][Full Text] [Related]
20. Recovery of systemic hyperinflammation in patients with severe SARS-CoV-2 infection.
Langnau C; Janing H; Kocaman H; Gekeler S; Günter M; Petersen-Uribe Á; Jaeger P; Koch B; Kreisselmeier KP; Castor T; Rath D; Gawaz MP; Autenrieth SE; Mueller KAL
Biomarkers; 2023 Feb; 28(1):97-110. PubMed ID: 36377411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
